![Sexual life and longevity ,[object Object],[object Object],[object Object],[object Object]](https://image.slidesharecdn.com/benetos2-110606061923-phpapp01/85/Benetos-2-1-320.jpg)
Recomendados
Recomendados
Mais conteúdo relacionado
Mais procurados
Mais procurados (20)
Destaque
Destaque (20)
Semelhante a Sexual longevity factors in the elderly
Semelhante a Sexual longevity factors in the elderly (20)
Mais de evivoudiklari
Último
Último (20)
Sexual longevity factors in the elderly
- 3. Naked-mole Rat The animal standing is a 24-year-old breeding female that is midway through gestation, and the animal sleeping is her 28.3-year-old naked mole-rat mate. This picture was taken a few days before he died R. Buffenstein: J Gerontol Biol Sciences, 2005, Vol. 60A, No. 11, 1369–1377
- 6. Sex and death: are they related?
- 7. G. Davey Smith, S. Frankel, J. Yarnell, Sex and death: are they related? The Caerphilly cohort study BMJ 1997;315:1641-1644 Sex and death: are they related?
- 9. Sex and death: are they related? The Caerphilly cohort study G. Davey Smith , S. Frankel , J. Yarnell , BMJ 1997
- 12. Sex and death: are they related? The Caerphilly cohort study 20-year follow-up S Ebrahim, M May, Y Ben Shlomo, P McCarron, S Frankel, J Yarnell, G Davey Smith J Epidemiol Community Health. 2002;56:99-102
- 14. Huang-Kuang Chen et al, Intern J Epidemiol , 2007
- 15. Huang-Kuang Chen et al, Intern J Epidemiol , 2007
- 16. Sexual activity and mortality in a Chinese population (>65 ans) Huang-Kuang Chen et al, Intern J Epidemiol , 2007
- 17. Huang-Kuang Chen et al, Intern J Epidemiol , 2007 Sexual activity and mortality in a Chinese population (>65 ans)
- 18. Sexual activity and mortality in a Chinese population (>65 ans) Huang-Kuang Chen et al, Intern J Epidemiol , 2007
- 19. Sexual activity and mortality in a Chinese population (>65 ans)
- 20. What is in the mind of younger people… … .Sexual activity in the very elderly is:
- 24. Secular trends in self reported sexual activity and satisfaction in Swedish 70 year olds: cross sectional survey of four populations 1971-2001 N. Beckman, M. Waern, I. Skoog BMJ 2008
- 25. N. Beckman,et al, BMJ, 2008
- 28. 2007: Dpt of Geriatrics, Nancy Age #Med #Pathol All: 82 5.8 3.2 Men : 78 5.3 3.2 Women : 84 6.0 3.2 A. Benetos : personal data Number of drugs used in the very elderly
- 29. Medications used in the very elderly 2007: Day hospital, Geriatrics, University of Nancy Benzodiazepines: 27% (H23%, F29%) Anti-depressors : 32% (H27%, F35%) Diuretics : 42% (H38%, F44%) Blockers: 24% (H35%, F19%) ACEI : 22% (H19%, F23%) AT1 antag : 18% (H12%, F21%) CCB: 18% (H8%, F23%) Statins : 12% (H15%, F10%) Anti-aggregants : 31% (H27%, F33%) Anti-coagulants : 15% (H12%, F17%) Pain killers : 30% (H23%, F33%) Anti-cholinesterase: 18% (H27%, 13%)
Notas do Editor
- This map compares the global levels of blood pressure control. In 1998, the Health Survey for England focused on cardiovascular disease. When compared with international values, the UK has the worst record for blood pressure control rates. Only 9% of hypertensive subjects achieve blood pressure <140/90 mm Hg. Sixty per cent of hypertensive patients in this survey remained on monotherapy. The survey suggested that improved detection greater use of non-pharmalogical measures increased use of >1 antihypertensive agent per patient would produce greater success in achieving target levels. This in turn could lead to major reductions in fatal and non-fatal cardiovascular events. References JNC-VI. Arch Intern Med 1997; 157 :2413 – 2446. Burt V et al . Hypertension 1995; 26 :60 – 69. Mancia G et al . Eur Heart J 1999; (suppl L) :L14 – L19. Primatesta et al . Hypertension 2001; 38 :827 –8 32.
- This map compares the global levels of blood pressure control. In 1998, the Health Survey for England focused on cardiovascular disease. When compared with international values, the UK has the worst record for blood pressure control rates. Only 9% of hypertensive subjects achieve blood pressure <140/90 mm Hg. Sixty per cent of hypertensive patients in this survey remained on monotherapy. The survey suggested that improved detection greater use of non-pharmalogical measures increased use of >1 antihypertensive agent per patient would produce greater success in achieving target levels. This in turn could lead to major reductions in fatal and non-fatal cardiovascular events. References JNC-VI. Arch Intern Med 1997; 157 :2413 – 2446. Burt V et al . Hypertension 1995; 26 :60 – 69. Mancia G et al . Eur Heart J 1999; (suppl L) :L14 – L19. Primatesta et al . Hypertension 2001; 38 :827 –8 32.
- This map compares the global levels of blood pressure control. In 1998, the Health Survey for England focused on cardiovascular disease. When compared with international values, the UK has the worst record for blood pressure control rates. Only 9% of hypertensive subjects achieve blood pressure <140/90 mm Hg. Sixty per cent of hypertensive patients in this survey remained on monotherapy. The survey suggested that improved detection greater use of non-pharmalogical measures increased use of >1 antihypertensive agent per patient would produce greater success in achieving target levels. This in turn could lead to major reductions in fatal and non-fatal cardiovascular events. References JNC-VI. Arch Intern Med 1997; 157 :2413 – 2446. Burt V et al . Hypertension 1995; 26 :60 – 69. Mancia G et al . Eur Heart J 1999; (suppl L) :L14 – L19. Primatesta et al . Hypertension 2001; 38 :827 –8 32.
- This map compares the global levels of blood pressure control. In 1998, the Health Survey for England focused on cardiovascular disease. When compared with international values, the UK has the worst record for blood pressure control rates. Only 9% of hypertensive subjects achieve blood pressure <140/90 mm Hg. Sixty per cent of hypertensive patients in this survey remained on monotherapy. The survey suggested that improved detection greater use of non-pharmalogical measures increased use of >1 antihypertensive agent per patient would produce greater success in achieving target levels. This in turn could lead to major reductions in fatal and non-fatal cardiovascular events. References JNC-VI. Arch Intern Med 1997; 157 :2413 – 2446. Burt V et al . Hypertension 1995; 26 :60 – 69. Mancia G et al . Eur Heart J 1999; (suppl L) :L14 – L19. Primatesta et al . Hypertension 2001; 38 :827 –8 32.